115 related articles for article (PubMed ID: 23415719)
1. The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer.
Tang D; Zhang Q; Zhao S; Wang J; Lu K; Song Y; Zhao L; Kang X; Wang J; Xu S; Tian L
Clin Biochem; 2013 Jul; 46(10-11):926-32. PubMed ID: 23415719
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
[TBL] [Abstract][Full Text] [Related]
3. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
[TBL] [Abstract][Full Text] [Related]
4. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of microRNA-155 expression in human breast cancer.
Chen J; Wang BC; Tang JH
J Surg Oncol; 2012 Sep; 106(3):260-6. PubMed ID: 22105810
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
[TBL] [Abstract][Full Text] [Related]
8. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.
Ota D; Mimori K; Yokobori T; Iwatsuki M; Kataoka A; Masuda N; Ishii H; Ohno S; Mori M
Int J Oncol; 2011 Apr; 38(4):955-62. PubMed ID: 21271219
[TBL] [Abstract][Full Text] [Related]
9. Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer.
Tang D; Piao Y; Zhao S; Mu X; Li S; Ma W; Song Y; Wang J; Zhao W; Zhang Q
Med Oncol; 2014 Jul; 31(7):26. PubMed ID: 24861922
[TBL] [Abstract][Full Text] [Related]
10. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
Wu ZS; Wu Q; Wang CQ; Wang XN; Huang J; Zhao JJ; Mao SS; Zhang GH; Xu XC; Zhang N
Cancer; 2011 Jul; 117(13):2842-52. PubMed ID: 21692045
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of heparanase in ovarian cancer and its clinical significance.
Zhang W; Chan H; Wei L; Pan Z; Zhang J; Li L
Oncol Rep; 2013 Nov; 30(5):2279-87. PubMed ID: 23982701
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of miR-148b in ovarian carcinoma and its clinical significance.
Chang H; Zhou X; Wang ZN; Song YX; Zhao F; Gao P; Chiang Y; Xu HM
Mol Med Rep; 2012 May; 5(5):1277-80. PubMed ID: 22344713
[TBL] [Abstract][Full Text] [Related]
13. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers.
Tavano F; di Mola FF; Piepoli A; Panza A; Copetti M; Burbaci FP; Latiano T; Pellegrini F; Maiello E; Andriulli A; di Sebastiano P
Pancreas; 2012 Nov; 41(8):1280-4. PubMed ID: 22836856
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
15. [Claudins as prognostic factors of breast cancer].
Szász MA
Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
[TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor-beta in normal mammary and tumor tissues: is it protective in breast carcinogenesis?
Park BW; Kim KS; Heo MK; Ko SS; Hong SW; Yang WI; Kim JH; Kim GE; Lee KS
Breast Cancer Res Treat; 2003 Jul; 80(1):79-85. PubMed ID: 12889601
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer.
Sevinc ED; Cecener G; Ak S; Tunca B; Egeli U; Gokgoz S; Tolunay S; Tasdelen I
Gene; 2016 Sep; 590(2):278-84. PubMed ID: 27236032
[TBL] [Abstract][Full Text] [Related]
18. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
19. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
20. High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer.
Rask L; Balslev E; Jørgensen S; Eriksen J; Flyger H; Møller S; Høgdall E; Litman T; Nielsen BS
APMIS; 2011 Oct; 119(10):663-73. PubMed ID: 21917003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
